The psychology of investors is fully on display here, but that doesn't have to be a negative trait. When there is a flow of information, both scientific and within the company itself, the investor is more informed about what it is they are getting into. When it comes to biotech, trawling through many ASX companies, many are very opaque on clarifying information and especially answering hard questions, thus giving the investor a lot of holes in which to fill with speculation. I think the uniqueness of this company, the "best in class and first in class" prize they are seeking to win, it has a place in any well constructed ASX biotech portfolio.
You want institutional investors on the register, doesn't Merchant hold a big position?
The psychology of investors is fully on display here, but that...
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |